Related Experiment Videos
Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1
K Van Laere1, L De Ceuninck, R Dom
1Division of Nuclear Medicine, Leuven University Hospital and K.U. Leuven, Herestraat 49, 3000, Leuven, Belgium. koen.vanlaere@uz.kuleuven.ac.be
Summary
123I-FP-beta-CIT (FP) demonstrated superior accuracy in diagnosing early parkinsonism compared to 99mTc-TRODAT-1 (TR). FP also showed better sensitivity for tracking disease progression in patients with parkinsonism.
Area of Science:
- Nuclear Medicine
- Neurology
- Radioligand Imaging
Background:
- Presynaptic dopamine transporter (DAT) imaging is crucial for diagnosing parkinsonism.
- 123I-FP-beta-CIT (FP) and 99mTc-TRODAT-1 (TR) are SPECT radioligands with fast pharmacokinetics.
- Assessing their comparative diagnostic utility in early parkinsonism is important.
Purpose of the Study:
- To compare the differential diagnostic power of FP and TR in early parkinsonism.
- To evaluate the sensitivity of FP and TR for detecting disease progression.
- To assess the accuracy of these radioligands in a clinical setting.
Main Methods:
- Cross-sectional study of 96 early parkinsonism patients and 10 controls.
- SPECT imaging using either FP (n=49) or TR (n=47) with semiquantitative analysis of transporter binding.
- Discriminant analysis with cross-validation for classification accuracy, sensitivity, and specificity.
Main Results:
- FP achieved 93% classification accuracy (95% sensitivity, 86% specificity) for contralateral putamen binding.
- TR achieved 87% classification accuracy (92% sensitivity, 70% specificity).
- FP showed significant correlation with disease duration for putamen binding and putamen/caudate ratio, unlike TR.
Conclusions:
- Both FP and TR exhibit high sensitivity for early parkinsonism diagnosis.
- FP demonstrates superior accuracy for differential diagnosis and better sensitivity for disease follow-up.
- FP is a more effective SPECT radioligand for early parkinsonism assessment and monitoring.